For instance, recently studies showed that CUL4A, whose overexpression is associated with elevated drug sensitivity, is a promising biomarker for several cancers (including breast cancer)24, 25, and here we revealed that CUL4A overexpression in breast cancer is mainly induced by its copy number gain. Here, CUL4A is linked to breast carcinoma.